1450MO Efficacy of a tailored approach with nivolumab and nivolumab/ipilimumab as immunotherapeutic boost in metastatic renal cell carcinoma: Final results of TITAN-RCC
Autor: | Grimm, M-O., Esteban Gonzalez, E., Barthelemy, P., Schmidinger, M., Busch, J., Perez Valderrama, B., Charnley, N., Schmitz, M., Schumacher, U., Baretton, G., Duran Martinez, I., De Velasco Oria, G.A., Priou, F., Maroto Rey, J.P., Albiges, L. |
---|---|
Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1206-S1207 |
Databáze: | ScienceDirect |
Externí odkaz: |